✦ LIBER ✦

Lack of effect of tumour infiltrating lymphocytes in patients with metastatic melanoma who failed to respond to interleukin 2

✍ Scribed by Dorval, T.; Pouillart, P.; Mathiot, C.; Fridman, W.H.; Escande, M.C.; Brandely, M.

Book ID: 122514888
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 146 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(05)80107-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of soluble interleukin-2 re

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours

✍ Lissoni, P; Barni, S; Rescaldani, R; Rovelli, F; Tancini, G 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 295 KB

Adjuvant adoptive immunotherapy with tum

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients

✍ R. Ridolfi; Emanuela Flamini; Angela Riccobon; F. De Paola; Roberta Maltoni; A. 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Ribavirin/interferon alpha-2b therapy is

Ribavirin/interferon alpha-2b therapy is very effective in the treatment of chronic hepatitis C genotype 2 & 3 patients who have failed to respond virologically to interferon monotherapy

✍ Neville Pimstone; Paul Sheykhzadeh; John Canio; Michelle Chiang; Jerry Powell; J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Thalidomide reduces serum C-reactive pro

Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy

✍ Igal Kedar; Wilmosh Mermershtain; Hefziba Ivgi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 341 KB

## Abstract Interleukin‐2 (IL‐2) has some antitumor activity in patients with renal cell carcinoma. It has been noted that response to IL‐2 and prognosis may be adversely affected by elevated serum levels of C‐reactive protein (CRP) or interleukin‐6 (IL‐6). We used thalidomide to treat patients wit

Ribavirin/interferon α-2b (IFN) therapy

Ribavirin/interferon α-2b (IFN) therapy is very effective in the treatment of chronic hepatitis C genotype 2&3 patients who have failed to respond virologically to IFN monotherapy

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A randomized study of neuroimmunotherapy

A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour

✍ P. Lissoni; S. Barni; V. Fossati; A. Ardizzoia; M. Cazzaniga; G. Tancini; F. Fri 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 334 KB